Precision Biomarker Resources: Immediate Processing of Affymetrix microRNA Assays
News Apr 14, 2009
Precision Biomarker Resources, a contract research organization based in Evanston, Illinois, is the first Service Provider to offer microRNA Profiling using the new GeneChip® miRNA Arrays recently released by Affymetrix, Inc.
Precision Biomarker provides RNA and microRNA (miRNA) profiling and data analysis services for pharmaceutical, biotechnology and academic researchers who use microarray methods for discovering biomarkers in their research. Because miRNAs are emerging as a major component in the regulation of gene expression, knowledge of their role in biological processes is becoming a focus of biomarker discovery.
Precision Biomarker has already processed miRNA arrays for a number of its research clients, using the new FlashTag® Biotin RNA Labeling kit created by Genisphere Inc. for the new GeneChip miRNA Array. The combined solution offers comprehensive miRNA coverage for 71 organisms on a single array and covers all the critical species models for scientists working in oncology, stem cell research, toxicology, neuroscience, infectious disease and other timely research areas.
“The new solution from Affymetrix and Genisphere is helping the research scientists we work with by providing one more piece of the puzzle. By providing both microRNA expression and traditional mRNA expression profiles from the same sample, we are able to offer a more complete look at cellular function which helps our clients understand the biology of their systems,” said David Paul, Ph.D., President of Precision Biomarker Resources. “MicroRNA arrays are an important new tool that helps provide critical insights into the molecular mechanisms underlying disease and drug response,” Dr. Paul added.
Novel Chemistry Technique Simplifies Late-Stage Modification of Drug CompoundsNews
Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.READ MORE
Pre-Diabetes Discovery Marks Step Towards Precision MedicineNews
Identification of three molecules that can be used to accurately assess pre-diabetes – a key predictor of conditions such as diabetes and high blood pressure – has brought precision medicine for humans a step closer.READ MORE
Comments | 0 ADD COMMENT
3rd Annual NGS Data Analysis and Informatics Conference
Feb 08 - Feb 09, 2018
3rd Annual Genome Editing & Engineering Conference
Feb 08 - Feb 09, 2018